食管-话题@MedSci

#食管#

815篇内容 | 2490人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1437736, encodeId=af0b143e736df, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=APS：抗精神病药五氟利多靶向PFKL抑制食管癌生长，可能具有广泛抗肿瘤效应, objectType=article, longId=727859, objectId=c222e2785955, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c222e2785955, replyNumber=0, likeNumber=83, createdTime=2022-05-27, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c222e2785955, moduleTitle=APS：抗精神病药五氟利多靶向PFKL抑制食管癌生长，可能具有广泛抗肿瘤效应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c222e2785955)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437735, encodeId=d9e0143e735ef, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=J Clin Oncol：RATIONALE-302研究证实Tislelizumab ( 替雷利珠单抗)二线治疗可改善晚期或转移性食管鳞状细胞癌（ESCC）患者的OS, objectType=article, longId=727477, objectId=0a19e27477f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a19e27477f4, replyNumber=0, likeNumber=71, createdTime=2022-05-22, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a19e27477f4, moduleTitle=J Clin Oncol：RATIONALE-302研究证实Tislelizumab ( 替雷利珠单抗)二线治疗可改善晚期或转移性食管鳞状细胞癌（ESCC）患者的OS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a19e27477f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437734, encodeId=245e143e73483, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=食管癌 TNM 分期，你真的掌握了吗？, objectType=article, longId=727125, objectId=71cbe2712544, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71cbe2712544, replyNumber=0, likeNumber=81, createdTime=2022-05-18, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71cbe2712544, moduleTitle=食管癌 TNM 分期，你真的掌握了吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=71cbe2712544)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437733, encodeId=bcac143e733b9, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=君实生物特瑞普利单抗联合化疗一线治疗食管鳞癌获得国家药品监督管理局批准, objectType=article, longId=727117, objectId=8db3e271176b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8db3e271176b, replyNumber=0, likeNumber=95, createdTime=2022-05-18, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8db3e271176b, moduleTitle=君实生物特瑞普利单抗联合化疗一线治疗食管鳞癌获得国家药品监督管理局批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8db3e271176b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437769, encodeId=efa7143e7693b, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=3张图，牢记胃食管反流的诊断和治疗！, objectType=article, longId=727004, objectId=b1afe27004de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1afe27004de, replyNumber=0, likeNumber=92, createdTime=2022-05-17, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1afe27004de, moduleTitle=3张图，牢记胃食管反流的诊断和治疗！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1afe27004de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437732, encodeId=7da9143e732d1, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=BMC Med：阿帕替尼+奥沙利铂+卡培他滨新辅助治疗局部晚期胃癌/胃食管交界处癌, objectType=article, longId=726038, objectId=a34fe2603805, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a34fe2603805, replyNumber=0, likeNumber=88, createdTime=2022-05-04, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a34fe2603805, moduleTitle=BMC Med：阿帕替尼+奥沙利铂+卡培他滨新辅助治疗局部晚期胃癌/胃食管交界处癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a34fe2603805)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437731, encodeId=6385143e731bd, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=3张图，牢记胃食管反流的诊断和治疗！, objectType=article, longId=726020, objectId=3395e2602052, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3395e2602052, replyNumber=0, likeNumber=71, createdTime=2022-05-04, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3395e2602052, moduleTitle=3张图，牢记胃食管反流的诊断和治疗！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3395e2602052)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437729, encodeId=9c74143e72979, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=BMJ：信迪利单抗联合化疗一线治疗可显著延长晚期/转移性食管鳞癌患者的生存期, objectType=article, longId=725552, objectId=9947e255526a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9947e255526a, replyNumber=0, likeNumber=96, createdTime=2022-04-28, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9947e255526a, moduleTitle=BMJ：信迪利单抗联合化疗一线治疗可显著延长晚期/转移性食管鳞癌患者的生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9947e255526a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437730, encodeId=baa7143e73070, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=晚期食管癌一线治疗又添新突破：PD-1单抗「替雷利珠单抗」全球3期临床试验达到主要终点, objectType=article, longId=725482, objectId=de0ae25482c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de0ae25482c5, replyNumber=0, likeNumber=62, createdTime=2022-04-28, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de0ae25482c5, moduleTitle=晚期食管癌一线治疗又添新突破：PD-1单抗「替雷利珠单抗」全球3期临床试验达到主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de0ae25482c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437727, encodeId=635a143e727b4, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=JGH: 球囊逆行经静脉闭塞后食管静脉曲张恶化对预后的影响, objectType=article, longId=724904, objectId=56a5e2490418, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56a5e2490418, replyNumber=0, likeNumber=71, createdTime=2022-04-25, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56a5e2490418, moduleTitle=JGH: 球囊逆行经静脉闭塞后食管静脉曲张恶化对预后的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56a5e2490418)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437728, encodeId=d32a143e7282c, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=J Clin Oncol：替雷利珠单抗二线治疗晚期/转移性食管鳞状细胞癌的效果, objectType=article, longId=724761, objectId=e0eae247611e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0eae247611e, replyNumber=0, likeNumber=64, createdTime=2022-04-23, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0eae247611e, moduleTitle=J Clin Oncol：替雷利珠单抗二线治疗晚期/转移性食管鳞状细胞癌的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0eae247611e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437726, encodeId=85fb143e726fc, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=指南共识 | 2022年新版食管癌诊疗指南, objectType=article, longId=724547, objectId=c0e6e245476f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0e6e245476f, replyNumber=0, likeNumber=124, createdTime=2022-04-20, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0e6e245476f, moduleTitle=指南共识 | 2022年新版食管癌诊疗指南, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0e6e245476f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437725, encodeId=aedb143e725f4, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=J Clin Oncol：EGFR抑制剂治疗EGFR扩增的胃食管交界癌的疗效, objectType=article, longId=724167, objectId=fa55e2416717, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa55e2416717, replyNumber=0, likeNumber=63, createdTime=2022-04-14, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa55e2416717, moduleTitle=J Clin Oncol：EGFR抑制剂治疗EGFR扩增的胃食管交界癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa55e2416717)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437723, encodeId=b9f6143e7238e, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=AACR 2022：围手术期帕博利珠单抗联合卡培他滨和奥沙利铂及辅助帕博利珠单抗治疗可切除胃和胃食管结合部(GC/GEJ)腺癌的II期试验, objectType=article, longId=724028, objectId=b171e24028fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b171e24028fa, replyNumber=0, likeNumber=65, createdTime=2022-04-13, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b171e24028fa, moduleTitle=AACR 2022：围手术期帕博利珠单抗联合卡培他滨和奥沙利铂及辅助帕博利珠单抗治疗可切除胃和胃食管结合部(GC/GEJ)腺癌的II期试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b171e24028fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437724, encodeId=3f28143e724be, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=AACR重磅：帕博利珠单抗加卡培他滨和奥沙利铂及辅助帕博利珠单抗治疗可切除的胃和胃食管交界处（GC/GEJ）腺癌的II期试验, objectType=article, longId=723982, objectId=1388e239827e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1388e239827e, replyNumber=0, likeNumber=45, createdTime=2022-04-12, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1388e239827e, moduleTitle=AACR重磅：帕博利珠单抗加卡培他滨和奥沙利铂及辅助帕博利珠单抗治疗可切除的胃和胃食管交界处（GC/GEJ）腺癌的II期试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1388e239827e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437719, encodeId=f49f143e71925, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=PeerJ：摄入油脂品种换一换，食管癌风险竟能差4倍？4个脂肪酸模式，1种可将ESCC风险翻一番，而另1种却打对折！, objectType=article, longId=723576, objectId=079de235769b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=079de235769b, replyNumber=0, likeNumber=119, createdTime=2022-04-07, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=079de235769b, moduleTitle=PeerJ：摄入油脂品种换一换，食管癌风险竟能差4倍？4个脂肪酸模式，1种可将ESCC风险翻一番，而另1种却打对折！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=079de235769b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437722, encodeId=ec85143e722bb, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=Cancer：帕博利珠单抗对比紫杉醇作为二线治疗亚洲晚期PD-L1阳性(CPS≧1)胃/胃食管交界处(GEJ)癌患者的疗效（KEYNOTE-063）, objectType=article, longId=723564, objectId=5743e2356484, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5743e2356484, replyNumber=0, likeNumber=79, createdTime=2022-04-07, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5743e2356484, moduleTitle=Cancer：帕博利珠单抗对比紫杉醇作为二线治疗亚洲晚期PD-L1阳性(CPS≧1)胃/胃食管交界处(GEJ)癌患者的疗效（KEYNOTE-063）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5743e2356484)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437718, encodeId=4ca9143e71843, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=Front Oncol：局部晚期或转移性食管鳞状细胞癌患者在化疗基础上联合放疗可改善患者预后, objectType=article, longId=723550, objectId=0c6ae23550d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c6ae23550d2, replyNumber=0, likeNumber=72, createdTime=2022-04-07, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c6ae23550d2, moduleTitle=Front Oncol：局部晚期或转移性食管鳞状细胞癌患者在化疗基础上联合放疗可改善患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c6ae23550d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437721, encodeId=bf07143e721e8, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=Clin Cancer Res：晚期食管癌采用纳武单抗二线治疗的长期预后, objectType=article, longId=723436, objectId=90b1e23436f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90b1e23436f5, replyNumber=0, likeNumber=74, createdTime=2022-04-05, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90b1e23436f5, moduleTitle=Clin Cancer Res：晚期食管癌采用纳武单抗二线治疗的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90b1e23436f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437717, encodeId=de8e143e71714, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=Clin Gastroenterol Hepatol：睡眠体位疗法可有效缓解夜间胃食管反流症状, objectType=article, longId=302241, objectId=c30f302241e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c30f302241e5, replyNumber=0, likeNumber=112, createdTime=2022-04-04, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c30f302241e5, moduleTitle=Clin Gastroenterol Hepatol：睡眠体位疗法可有效缓解夜间胃食管反流症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c30f302241e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

食管

2020-05-29

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

APS：抗精神病药五氟利多靶向PFKL抑制食管癌生长，可能具有广泛抗肿瘤效应

2022-05-27

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

J Clin Oncol：RATIONALE-302研究证实Tislelizumab ( 替雷利珠单抗)二线治疗可改善晚期或转移性食管鳞状细胞癌（ESCC）患者的OS

2022-05-22

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

食管癌 TNM 分期，你真的掌握了吗？

2022-05-18

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

君实生物特瑞普利单抗联合化疗一线治疗食管鳞癌获得国家药品监督管理局批准

2022-05-18

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

3张图，牢记胃食管反流的诊断和治疗！

2022-05-17

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

BMC Med：阿帕替尼+奥沙利铂+卡培他滨新辅助治疗局部晚期胃癌/胃食管交界处癌

2022-05-04

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

3张图，牢记胃食管反流的诊断和治疗！

2022-05-04

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

BMJ：信迪利单抗联合化疗一线治疗可显著延长晚期/转移性食管鳞癌患者的生存期

2022-04-28

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

晚期食管癌一线治疗又添新突破：PD-1单抗「替雷利珠单抗」全球3期临床试验达到主要终点

2022-04-28

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

JGH: 球囊逆行经静脉闭塞后食管静脉曲张恶化对预后的影响

2022-04-25

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

J Clin Oncol：替雷利珠单抗二线治疗晚期/转移性食管鳞状细胞癌的效果

2022-04-23

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

指南共识 | 2022年新版食管癌诊疗指南

2022-04-20

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

J Clin Oncol：EGFR抑制剂治疗EGFR扩增的胃食管交界癌的疗效

2022-04-14

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

AACR 2022：围手术期帕博利珠单抗联合卡培他滨和奥沙利铂及辅助帕博利珠单抗治疗可切除胃和胃食管结合部(GC/GEJ)腺癌的II期试验

2022-04-13

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

AACR重磅：帕博利珠单抗加卡培他滨和奥沙利铂及辅助帕博利珠单抗治疗可切除的胃和胃食管交界处（GC/GEJ）腺癌的II期试验

2022-04-12

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

PeerJ：摄入油脂品种换一换，食管癌风险竟能差4倍？4个脂肪酸模式，1种可将ESCC风险翻一番，而另1种却打对折！

2022-04-07

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

Cancer：帕博利珠单抗对比紫杉醇作为二线治疗亚洲晚期PD-L1阳性(CPS≧1)胃/胃食管交界处(GEJ)癌患者的疗效（KEYNOTE-063）

2022-04-07

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

Front Oncol：局部晚期或转移性食管鳞状细胞癌患者在化疗基础上联合放疗可改善患者预后

2022-04-07

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

Clin Cancer Res：晚期食管癌采用纳武单抗二线治疗的长期预后

2022-04-05

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

Clin Gastroenterol Hepatol：睡眠体位疗法可有效缓解夜间胃食管反流症状

2022-04-04

科室
- - 订阅+
  - 更多科室
工具
服务